Frequently Asked Questions - Abstract
Can I still submit my abstract?
No, it is no longer possible to submit your abstract. The deadline was 18 May 23.59 CEST (Central European Summer Time).
When and how will I know if I submitted my abstract correctly?
You will receive an automatic confirmation e-mail immediately after submitting your abstract. In addition, your submission will be confirmed by the ECNP Office via e-mail within two weeks after submission. If you have not received a confirmation within this period, please notify the ECNP Office via e-mail.
Can I make changes to my abstract after submission?
Before the deadline of 18 May you can ask the ECNP Office to reopen the submission. After the deadline, when abstracts are under review, no changes are allowed.
When and how will I know if my abstract has been accepted?
The presenting author will be informed of the decision of the scientific review committee by 20 July 2021.The abstract will be reviewed for one of the 3 review outcomes if you have finalised your submission on or before 18 May 2021.
Where can I find the congress abstracts?
The abstracts that have been accepted will be posted on the online programme, the ECNP app and if accepted for publication on the digital congress supplement to the journal European Neuropsychopharmacology.
Are posters available on the ECNP website?
No, ePosters are only available via the online platform of the congress. The abstracts of the posters will be posted on the website before 1 September 2021.
How can I register as an abstract submitter?
When submitting an abstract you are asked to wait with registration until the outcome of the review is known (20 July 2021). All abstract submitters will be offered the early registration fee (regardless of the outcome). The early registration fee is applicable only if you register and pay within 15 days after receiving the review outcome. Selected Early Career Scientists (who fit the ECS criteria) will received free registration.
How can I register for free as an ECS* abstract submitter?
The registration is free for ECS presenting authors, residing in a country within Europe**, if the abstract is accepted for publication in the digital congress supplement to the journal European Neuropsychopharmacology. To be eligible for the free registration the abstract must be submitted by the presenting author (who fits the ECS criteria) and he/she has uploaded the proof of age document during the submission. The free registration is offered after the outcome is known (20 July 2021). Registrations made before this date will not be refunded.
* Early Career Scientist
**Europe being the 47 countries of the Council of Europe plus Israel and Belarus.
Where can I find information about application for a CDE Grant?
The CDE Grant no longer exists, but abstract submitters that are an Early Career Scientist (view criteria) or residents of an European Country with a Developing Economy (CDE)* are candidates to win an Excellent Award. To win this award you do not need to apply. Further details can be found here.
*CDE-countries within Europe are: Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Georgia, Kosovo, Macedonia-FYR, Moldova, Montenegro, Poland, Romania, Russian Federation, Serbia, Turkey, Ukraine.
Can I present my poster online only?
You will only know if you can present a poster online when you have received the outcome of the review by 20 July 2021, as the review will determine if you are selected for in-person and online presentation or online presentation only.